Effect of Cardiac Resynchronization Therapy on Left Ventricular Remodeling in Patients with Cardiac Sarcoidosis

Cardiac resynchronization therapy (CRT) has been shown to be beneficial in patients with medically refractory heart failure. While it has been found to be effective in a wide range of etiologies for non-ischemic cardiomyopathy, its role in improving remodeling and survival of patients with cardiac sarcoidosis (CS) remains undefined. We performed a retrospective review of all patients at our institution with CS who underwent implantation of a CRT device between 2007 and 2017. The outcomes of this population were compared to the outcomes of a cohort of patients with non-ischemic cardiomyopathy with an etiology other than sarcoidosis.

Source: The American Journal of Cardiology - October 20, 2018 Category: Cardiology Authors: Divyang Patel, Kevin M. Trulock, Saleem Toro, Adam Grimaldi, Matthew Gonzalez, Laurie Ann Moennich, Eiran Z. Gorodeski, Emer Joyce, Mark Niebauer, Bruce L. Wilkoff, Niraj Varma, John W. Rickard Source Type: research